Back to search

Article

Risk Stratification and Adjuvant Chemotherapy Based on Clinical Risk Scores of Patients with Stage IB-IIA Non-Small Cell Lung Cancer

2021-05-05

Abstract excerpt

<title>Abstract</title> <p><bold>Background </bold>Despite the heterogeneity among patients with stage IB-IIA non-small cell lung cancer (NSCLC), clinical applicable model to identify those patients to receive adjuvant chemotherapy after radical resection is limited. We aimed to developed a clinical tool of benefits from adjuvant chemotherapy for risk stratification and individualized management in this heterogen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
73469a70-5f5a-5beb-a8b6-beb88e6435cd
DOI
10.21203/rs.3.rs-441031/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Risk Stratification and Adjuvant Chemotherapy Based on Clinical Risk Scores of Patients with Stage IB-IIA Non-Small Cell Lung CancerDOI 10.21203/rs.3.rs-441031/v1
Risk stratification and adjuvant chemotherapy after radical resection based on the clinical risk scores of patients with stage IB-IIA non-small cell lung cancer.Semantic proximity
The adjuvant chemotherapy can be omitted for lepidic predominant lung adenocarcinoma in stage IB of the 8th TNM staging system.Semantic proximity
The 5-year survival outcomes analysis of EGFR-TKI or/and chemotherapy as initial adjuvant therapy for completely resected IIIA non-small cell lung cancer.Semantic proximity
Redefining the Risk of Surgery for Clinical Stage IIIA (N2) Non-Small Cell Lung Cancer: A Pooled Analysis of the STS GTSD and ESTS RegistrySemantic proximity
Effect of adjuvant EGFR-TKI therapy on the prognosis of pathological stage I invasive lung adenocarcinoma with sensitive EGFR mutations.Semantic proximity
The impact of epidermal growth factor receptor mutation status on adjuvant chemotherapy for patients with high-risk stage I lung adenocarcinoma.Semantic proximity
Outcomes of adjuvant epithelial growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) treatment for EGFR-mutant non-small-cell lung cancer: a propensity-score analysis.Semantic proximity
Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC.Semantic proximity
Persistent increase and improved survival of stage I lung cancer based on a large-scale real-world sample of 26,226 cases.Semantic proximity
A meta-analysis of adjuvant EGFR-TKIs for patients with EGFR mutation of resected non-small cell lung cancer.Semantic proximity
Five-year Survival Analyses on Non-Pathological Complete Response Esophageal Squamous Cell Carcinoma Patients after Neoadjuvant Regimens plus Surgery: a Propensity Score Matching, Real-World Cohort StudySemantic proximity
[Analysis of treatment failure phenotype and prognostic factors of stage Ⅰ non-small cell lung cancer].Semantic proximity
Select a neighboring publication to make it the new centre.